Mainz Biomed B.V. (MYNZ): Price and Financial Metrics
MYNZ Price/Volume Stats
| Current price | $4.49 | 52-week high | $48.80 |
| Prev. close | $4.60 | 52-week low | $3.65 |
| Day low | $4.31 | Volume | 39,895 |
| Day high | $4.63 | Avg. volume | 44,061 |
| 50-day MA | $8.14 | Dividend yield | N/A |
| 200-day MA | $18.83 | Market Cap | 8.98M |
MYNZ Stock Price Chart Interactive Chart >
Mainz Biomed B.V. (MYNZ) Company Bio
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
MYNZ Price Returns
| 1-mo | -48.98% |
| 3-mo | -56.54% |
| 6-mo | -66.50% |
| 1-year | -90.32% |
| 3-year | -98.92% |
| 5-year | N/A |
| YTD | -90.32% |
| 2023 | -83.66% |
| 2022 | -31.67% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...